Sartorius/€SRT3

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Sartorius

Sartorius AG, trading under the ticker symbol SRT3, is a global provider of laboratory and bioprocess technologies, offering products and services that cater to the needs of the biopharmaceutical and research industries. Founded in 1870 and headquartered in Göttingen, Germany, the company specializes in filtration, fermentation, fluid management, and laboratory products, supporting clients ranging from research facilities to large-scale biopharmaceutical manufacturers. Operating internationally, Sartorius is crucial in enabling the development and production of biotech medications and vaccines, solidifying its role as a crucial player in the life sciences and biotechnology sectors.

Ticker

€SRT3

Primary listing

XETRA

Industry

Life Sciences Tools & Services

Employees

13,573

ISIN

DE0007165631

Sartorius Metrics

BasicAdvanced
€13B
-
-
1.33
€0.74
0.35%

What the Analysts think about Sartorius

Analyst ratings (Buy, Hold, Sell) for Sartorius stock.

Bulls say / Bears say

Sartorius reported a 6.71% year-over-year increase in revenue for Q4 2024, indicating strong financial performance. (Google Finance)
The company's net operating cash flow tripled to €139 million in Q1 2025, showcasing improved financial health. (Seeking Alpha)
Analysts forecast earnings to grow by 28.44% per year, suggesting strong future growth potential. (Simply Wall St)
Sartorius has a high level of debt, which could pose financial risks. (Simply Wall St)
Profit margins have decreased from 4.5% to 2.8% year-over-year, indicating potential profitability concerns. (Simply Wall St)
The stock is trading at a high P/E ratio of 156.22, suggesting it may be overvalued. (Google Finance)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.

Sartorius Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Sartorius Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €SRT3

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs